Integrated Biopharma Price on January 22, 2021
| INBPDelisted Stock | USD 0.23 0.01 4.55% |
If you're considering investing in Integrated OTC Stock, it is important to understand the factors that can impact its price. As of today, the current price of Integrated Biopharma stands at 0.23, as last reported on the 18th of April 2024, with the highest price reaching 0.23 and the lowest price hitting 0.22 during the day. Integrated Biopharma appears to be out of control, given 3 months investment horizon. Integrated Biopharma holds Efficiency (Sharpe) Ratio of 0.0723, which attests that the entity had a 0.0723% return per unit of risk over the last 3 months. We have found twenty-four technical indicators for Integrated Biopharma, which you can use to evaluate the volatility of the firm. Please utilize Integrated Biopharma's Standard Deviation of 5.22, market risk adjusted performance of (0.29), and Risk Adjusted Performance of (0) to validate if our risk estimates are consistent with your expectations.
Integrated OTC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Integrated |
Sharpe Ratio = 0.0723
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | INBP | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.67 actual daily | 50 50% of assets are less volatile |
Expected Return
| 0.41 actual daily | 8 92% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Integrated Biopharma is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Integrated Biopharma by adding it to a well-diversified portfolio.
Integrated Biopharma Valuation on January 22, 2021
It is possible to determine the worth of Integrated Biopharma on a given historical date. On January 22, 2021 Integrated was worth 0.83 at the beginning of the trading date compared to the closed value of 0.83. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Integrated Biopharma otc stock. Still, in general, we apply an absolute valuation method to find Integrated Biopharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Integrated Biopharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Integrated Biopharma's related companies.
| Open | High | Low | Close | Volume | |
04/04/2022 | 0.83 | 0.83 | 0.83 | 0.83 | 200.00 |
| 0.83 | 0.83 | 0.83 | 0.83 | 1.00 |
| Backtest Integrated Biopharma | | | Integrated Biopharma History | | | Integrated Biopharma Valuation | Next |
Integrated Biopharma Trading Date Momentum on January 22, 2021
The event impact on price volatility cannot be determined at this time. Please check this event after some time to allow current data to be analyzed.Integrated Biopharma Fundamentals Correlations and Trends
By evaluating Integrated Biopharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Integrated Biopharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Integrated financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Integrated Biopharma OTC Stock history
Integrated Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Integrated is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Integrated Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Integrated Biopharma stock prices may prove useful in developing a viable investing in Integrated Biopharma
Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey. Integrated Biopharma operates under Packaged Foods classification in the United States and is traded on OTC Exchange. It employs 147 people.
Integrated Biopharma OTC Stock Technical Analysis
Integrated Biopharma technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
Price Boundaries
Integrated Biopharma Period Price Range
Low | April 4, 2022
| High |
0.83 | 0.83 |
Integrated Biopharma April 18, 2024 Market Strength
Market strength indicators help investors to evaluate how Integrated Biopharma otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Integrated Biopharma shares will generate the highest return on investment. By undertsting and applying Integrated Biopharma otc stock market strength indicators, traders can identify Integrated Biopharma entry and exit signals to maximize returns
Integrated Biopharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Integrated Biopharma's price direction in advance. Along with the technical and fundamental analysis of Integrated OTC Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Integrated to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.13) | |||
| Total Risk Alpha | (0.49) | |||
| Treynor Ratio | (0.30) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Integrated Biopharma information on this page should be used as a complementary analysis to other Integrated Biopharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Integrated OTC Stock
If you are still planning to invest in Integrated Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Integrated Biopharma's history and understand the potential risks before investing.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |